Just diagnosed with Heparin-induced thrombocytopenia?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Heparin-induced thrombocytopenia, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Heparin-induced thrombocytopenia hub →Overview
Heparin-induced thrombocytopenia is a rare condition. Also known as Classic HAT, Classic HIT, Classic heparin-associated thrombocytopenia, HITT, Heparin-induced-immune thrombocytopenia. Tomeko brings together the specialists, research, clinical trials, treatments and community for Heparin-induced thrombocytopenia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:3325 · ICD-10 D69.5 · GARD 0002650
Find care for Heparin-induced thrombocytopenia
Authoritative references for Heparin-induced thrombocytopenia
Research & market landscape for Heparin-induced thrombocytopenia
Following Heparin-induced thrombocytopenia for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Heparin-induced thrombocytopenia — the real-world landscape behind the condition, in one place.
- Latest Heparin-induced thrombocytopenia research on PubMed ↗
- Recruiting Heparin-induced thrombocytopenia trials on ClinicalTrials.gov ↗
- Explore the Heparin-induced thrombocytopenia research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Heparin-induced thrombocytopenia and every rare condition. See how Tomeko works with industry →
Common questions
What is Heparin-induced thrombocytopenia?
Heparin-induced thrombocytopenia is a rare condition. Also known as Classic HAT, Classic HIT, Classic heparin-associated thrombocytopenia, HITT, Heparin-induced-immune thrombocytopenia. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Heparin-induced thrombocytopenia together in one place.
What are the symptoms of Heparin-induced thrombocytopenia?
Symptoms of Heparin-induced thrombocytopenia vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Heparin-induced thrombocytopenia.
How is Heparin-induced thrombocytopenia treated?
Treatment for Heparin-induced thrombocytopenia depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Heparin-induced thrombocytopenia, and review current options with them.
What causes Heparin-induced thrombocytopenia — is it genetic?
The cause and inheritance of Heparin-induced thrombocytopenia are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Heparin-induced thrombocytopenia can explain what it means for you and your family.
I was just diagnosed with Heparin-induced thrombocytopenia — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Heparin-induced thrombocytopenia, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Heparin-induced thrombocytopenia?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Heparin-induced thrombocytopenia, filtered to your area.
Are there clinical trials for Heparin-induced thrombocytopenia?
Tomeko shows live, recruiting studies for Heparin-induced thrombocytopenia from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: